Cargando…
Cell therapy in Huntington's disease: Taking stock of past studies to move the field forward
Huntington's disease (HD) is a rare inherited neurodegenerative disease that manifests mostly in adulthood with progressive cognitive, behavioral, and motor dysfunction. Neuronal loss occurs predominantly in the striatum but also extends to other brain regions, notably the cortex. Most patients...
Autores principales: | Bachoud‐Lévi, Anne‐Catherine, Massart, Renaud, Rosser, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234449/ https://www.ncbi.nlm.nih.gov/pubmed/33176057 http://dx.doi.org/10.1002/stem.3300 |
Ejemplares similares
-
Treatment biomarkers for ADHD: Taking stock and moving forward
por: Michelini, Giorgia, et al.
Publicado: (2022) -
International Guidelines for the Treatment of Huntington's Disease
por: Bachoud-Lévi, Anne-Catherine, et al.
Publicado: (2019) -
Self-Reported Social Relationship Capacities Predict Motor, Functional and Cognitive Decline in Huntington’s Disease
por: Lemercier, Pablo, et al.
Publicado: (2022) -
Cognitive decline in Huntington’s disease in the Digitalized Arithmetic Task (DAT)
por: Lunven, Marine, et al.
Publicado: (2021) -
Editorial: Synthesizing the Evidence on Prisoner Health—Taking Stock and Moving Forward
por: Fazel, Seena
Publicado: (2018)